epigallocatechin gallate has been researched along with crizotinib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, W; Zhu, K | 1 |
Honda, Y; Ichihara, E; Kiura, K; Kubo, T; Murakami, T; Ninomiya, T; Ochi, N; Takigawa, N; Tanimoto, M; Yamane, H; Yasugi, M | 1 |
2 other study(ies) available for epigallocatechin gallate and crizotinib
Article | Year |
---|---|
Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1.
Topics: Apoptosis; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Crizotinib; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Osteosarcoma; Polyphenols; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Tea | 2016 |
Effects of (-)-epigallocatechin-3-gallate on EGFR- or Fusion Gene-driven Lung Cancer Cells.
Topics: Anaplastic Lymphoma Kinase; Animals; Blood Proteins; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Crizotinib; Disease Models, Animal; ErbB Receptors; Female; Gene Rearrangement; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Oncogene Proteins, Fusion; Polyphenols; Protein S; Protein-Tyrosine Kinases; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Tea | 2017 |